scispace - formally typeset
Open AccessJournal ArticleDOI

Classification of Cannabis Cultivars Marketed in Canada for Medical Purposes byQuantification of Cannabinoids and Terpenes Using HPLC-DAD and GC-MS

TLDR
Cannabis classification using a full spectrum of compounds will more closely meet the practical needs of cannabis applications in clinical research, insdustrial production, and patients’ self-production in Canada and will contribute to the standardization of commercially-available cannabis cultivars in support of a continuously growing market.
Abstract
For over a century, research on cannabis has been hampered by its legal status as a narcotic. The recent legalization of cannabis for medical purposes in North America requires rigorous standardization of its phytochemical composition in the interest of consumer safety and medicinal efficacy. To utilize medicinal cannabis as a predictable medicine, it is crucial to classify hundreds of cultivars with respect to dozens of therapeutic cannabinoids and terpenes, as opposed to the current industrial or forensic classifications that only consider the primary cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD). We have recently developed and validated analytical methods using high-pressure liquid chromatography (HPLC-DAD) to quantify cannabinoids and gas chromatography with mass spectroscopy (GC-MS) to quantify terpenes in cannabis raw material currently marketed in Canada. We classified 32 cannabis samples from two licensed producers into four clusters based on the content of 10 cannabinoids and 14 terpenes. The classification results were confirmed by cluster analysis and principal component analysis in tandem, which were distinct from those using only THC and CBD. Cannabis classification using a full spectrum of compounds will more closely meet the practical needs of cannabis applications in clinical research, insdustrial production, and patients’ self-production in Canada. As such, this holistic classification methodology will contribute to the standardization of commercially-available cannabis cultivars in support of a continuously growing market.

read more

Citations
More filters
Journal ArticleDOI

Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus.

TL;DR: Terpenes' medicinal properties are supported by numerous in vitro, animal and clinical trials and show anti-inflammatory, antioxidant, analgesic, anticonvulsive, antidepressant, anxiolytic, anticancer, antitumor, neuroprotective, anti-mutagenic,Anti-allergic, antibiotic and anti-diabetic attributes, among others.
Journal ArticleDOI

Terpenes in Cannabis sativa - From plant genome to humans.

TL;DR: There is concern about lack of consistency with regard to the terpene and cannabinoid composition of different cannabis 'strains'.
Journal ArticleDOI

Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes.

TL;DR: This comprehensive profile of bioactive compounds can form a baseline of reference values useful for research and clinical studies to understand the “entourage effect” of cannabis as a whole, and also to rediscover therapeutic potential for each part of cannabis from their traditional use by applying modern scientific methodologies.
Journal ArticleDOI

Accumulation of bioactive metabolites in cultivated medical Cannabis.

TL;DR: A simple extraction and analysis method is reported, amenable to use by commercial laboratories for the detection and quantification of both cannabinoids and terpenoids, which could play a role in the beneficial medical effects of different cannabis strains.
Journal ArticleDOI

Fast Detection of 10 Cannabinoids by RP-HPLC-UV Method in Cannabis sativa L.

TL;DR: The present validated RP-HPLC-UV method allows determination of the main cannabinoids in Cannabis sativa L. inflorescences and appropriate legal classification as hemp or drug-type.
References
More filters
Journal ArticleDOI

An examination of the effect of six types of error perturbation on fifteen clustering algorithms

TL;DR: An evaluation of several clustering methods indicated that the hierarchical methods were differentially sensitive to the type of error perturbation and two alternative starting procedures for the nonhierarchical methods produced greatly enhanced cluster recovery and were found to be robust to all of the types of error examined.
Journal ArticleDOI

Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects

TL;DR: Particular focus will be placed on phytocannabinoid‐terpenoid interactions that could produce synergy with respect to treatment of pain, inflammation, depression, anxiety, addiction, epilepsy, cancer, fungal and bacterial infections (including methicillin‐resistant Staphylococcus aureus).
Journal ArticleDOI

A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae).

TL;DR: A two-species concept of Cannabis is supported by the determined frequencies of B(D) and B(T) in sample populations of 157 Cannabis accessions determined from CBD and THC banding patterns, visualized by starch gel electrophoresis.
Journal ArticleDOI

Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?

TL;DR: Good evidence shows that secondary compounds in cannabis may enhance the beneficial effects of THC, and other cannabinoid and non-cannabinoid compounds in herbal cannabis or its extracts may reduce THC-induced anxiety, cholinergic deficits, and immunosuppression.
Journal ArticleDOI

A practical and natural taxonomy for cannabis

Ernest Small, +1 more
- 01 Aug 1976 - 
Related Papers (5)